NCT07469774 2026-03-13BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid TumorsBiocity Biopharmaceutics Co., Ltd.Phase 1/2 Not yet recruiting111 enrolled
NCT06293651 2025-02-12Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid TumorsDong-A ST Co., Ltd.Phase 1/2 Recruiting125 enrolled